Alignment Healthcare (NASDAQ:ALHC) EVP Joseph Konowiecki Sells 25,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) EVP Joseph Konowiecki sold 25,000 shares of the firm’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $23.00, for a total transaction of $575,000.00. Following the completion of the transaction, the executive vice president directly owned 1,128,816 shares in the company, valued at $25,962,768. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare Stock Up 2.2%

NASDAQ ALHC opened at $23.21 on Friday. The firm has a market cap of $4.80 billion, a PE ratio of 257.84, a P/E/G ratio of 3.07 and a beta of 1.14. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $23.87. The business’s fifty day simple moving average is $18.76 and its 200-day simple moving average is $19.58. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.04. The firm had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The company’s quarterly revenue was up 33.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.05) EPS. As a group, equities analysts anticipate that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current year.

Hedge Funds Weigh In On Alignment Healthcare

Several large investors have recently made changes to their positions in the business. Hudson Bay Capital Management LP purchased a new position in Alignment Healthcare during the 3rd quarter valued at about $4,581,000. 1492 Capital Management LLC lifted its position in shares of Alignment Healthcare by 61.8% in the fourth quarter. 1492 Capital Management LLC now owns 324,865 shares of the company’s stock worth $6,416,000 after buying an additional 124,143 shares during the last quarter. Cinctive Capital Management LP bought a new stake in Alignment Healthcare during the third quarter worth approximately $3,814,000. William Blair Investment Management LLC grew its stake in Alignment Healthcare by 43.4% in the 3rd quarter. William Blair Investment Management LLC now owns 2,119,952 shares of the company’s stock valued at $36,993,000 after buying an additional 641,381 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in Alignment Healthcare by 5.0% during the 3rd quarter. Vanguard Group Inc. now owns 13,968,584 shares of the company’s stock valued at $243,752,000 after purchasing an additional 664,769 shares during the period. Institutional investors own 86.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on ALHC. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 28th. Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. UBS Group increased their price target on Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Weiss Ratings raised shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. Finally, Raymond James Financial set a $22.00 target price on shares of Alignment Healthcare in a research report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Alignment Healthcare presently has an average rating of “Moderate Buy” and an average price target of $24.30.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.